Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer

収録刊行物

• Proc Am Soc Clin Oncol.

  Proc Am Soc Clin Oncol. 23 632s-, 2004